AICC

[04-06 dic 2023] L’AQUILA – Technological advances in dissecting complex disease
landscapes have catapulted scientists into the precision medicine era. The lesson of precision medicine might be that treatment should be personalized, as each patient features a unique disease’s molecular and immune landscape.
High-throughput methods in genomics, transcriptomics, metabolomics and proteomics have significantly improved illness treatment and prevention, and precision medicine is nowadays revolutionizing the way drugs are developed, benefiting patients, the pharmaceutical industry, and the whole society.

[01-03 dic 2022] NAPLES – Hybrid meeting – Organoid technology currently represents a fundamental tool for both basic and translational research. Their potential to faithfully recapitulate human disease is the key for biomedical research in the present and in a near future. The aim of this congress is to gather national and international experts in the field to provide updated knowledge on organoids as models of human diseases.

[22-24 nov] TORINO – Hybrid meeting – Dissecting metabolic circuitries in cancer cells and microenvironment: how to learn from bad lessons to develop new therapeutic opportunities